Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.

Kiss, Norbert; Lorincz, Kende; Medvecz, Márta; Fésus, Luca; Csuha, Péter; Hermányi, Zsolt; Wikonkál, Norbert Miklós

Kiss, Norbert; Lorincz, Kende; Medvecz, Márta; Fésus, Luca; Csuha, Péter; Hermányi, Zsolt; Wikonkál, Norbert Miklós.

Kiss N; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Lorincz K; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Medvecz M; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Fésus L; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Csuha P; 3rd Department of Internal Medicine, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Hermányi Z; 3rd Department of Internal Medicine, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
Wikonkál NM; Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.

Dermatol Ther ; 33(6): e14186, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-721124

Subject(s)

Antibodies, Monoclonal/therapeutic use; Biological Products/therapeutic use; COVID-19/virology; Dermatologic Agents/therapeutic use; Psoriasis/drug therapy; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2/pathogenicity; Aged; Antibodies, Monoclonal/adverse effects; Antiviral Agents/therapeutic use; Biological Products/adverse effects; COVID-19/diagnosis; COVID-19/immunology; Dermatologic Agents/adverse effects; Host-Pathogen Interactions; Humans; Male; Psoriasis/diagnosis; Psoriasis/immunology; Pulmonary Disease, Chronic Obstructive/diagnosis; Pulmonary Disease, Chronic Obstructive/immunology; SARS-CoV-2/drug effects; SARS-CoV-2/immunology; Treatment Outcome; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / Biological Products / Pulmonary Disease, Chronic Obstructive / Dermatologic Agents / SARS-CoV-2 / COVID-19 / Antibodies, Monoclonal Type of study: Case report / Diagnostic study / Prognostic study Limits: Aged / Humans / Male Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14186

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google